CAR-T療法パイプライン分析の世界市場レポート2023年

世界のCAR-T療法パイプライン分析市場は、2021年の14億米ドルから2022年には18億米ドルに、年平均成長率（CAGR）28.6％で成長すると予測されます。ロシア・ウクライナ戦争は、少なくとも短期的にはCOVID-19のパンデミックからの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を与えています。キメラ抗原受容体-T療法市場は、2026年にはCAGR18.5%で35億5000万米ドルに成長すると予想されています。

2022年のCAR-T療法の世界市場において、北米が最大の地域となりました。西欧は、CAR-T療法市場で2番目に大きな地域でした。キメラ抗原受容体-T療法市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 CAR-T療法市場の特徴

第3章 CAR-T療法の市場動向と戦略

第4章 CAR-T療法市場-マクロ経済シナリオ

第5章 CAR-T療法の市場規模と成長

• 世界のCAR-T療法市場の実績、2017年から2022年
  • 市場の促進要因
  • 市場の抑制要因
• 世界のCAR-T療法市場の予測、2022-2027F、2032F
  • 市場の促進要因
  • 市場の抑制要因

第6章 CAR-T療法市場セグメンテーション

• 世界のCAR-T療法市場、タイプ別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
• 単剤療法
• 併用療法
• 世界のCAR-T療法市場、標的抗原別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
• CD19
• CD22
• その他の標的抗原
• 世界のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
• 急性リンパ芽球性白血病
• びまん性大細胞型B細胞リンパ腫
• 濾胞性リンパ腫
• 慢性リンパ性白血病
• 多発性骨髄腫
• その他のアプリケーション

第7章 CAR-T療法市場の地域および国分析

• 世界のCAR-T療法市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
• 世界のCAR-T療法市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋CAR-T療法市場

• アジア太平洋CAR-T療法市場概要
• 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
• アジア太平洋CAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国のCAR-T療法市場

• 中国CAR-T療法市場概要
• 中国のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドのCAR-T療法市場

• インドのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本のCAR-T療法市場

• 日本のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアのCAR-T療法市場

• オーストラリアのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアのCAR-T療法市場

• インドネシアのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国のCAR-T療法市場

• 韓国のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧のCAR-T療法市場

• 西欧のCAR-T療法市場概要
• 西欧のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国のCAR-T療法市場

• 英国のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツのCAR-T療法市場

• ドイツのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスのCAR-T療法市場

• フランスのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧のCAR-T療法市場

• 東欧のCAR-T療法市場概要
• 東欧のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアのCAR-T療法市場

• ロシアのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米CAR-T療法市場

• 北米CAR-T療法市場概要
• 北米のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国のCAR-T療法市場

• 米国CAR-T療法市場概要
• 米国CAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米のCAR-T療法市場

• 南米CAR-T療法市場概要
• 南米のCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルのCAR-T療法市場

• ブラジルのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東のCAR-T療法市場

• 中東CAR-T療法市場概要
• 中東CAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカのCAR-T療法市場

• アフリカCAR-T療法市場概要
• アフリカのCAR-T療法市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 CAR-T療法市場の競合情勢と企業プロファイル

• CAR-T療法市場の競合情勢
• CAR-T療法市場の企業プロファイル
  • Novartis AG
  • Kite Pharma
  • Pfizer Inc
  • Juno Therapeutics
  • Celgene Corporation

第28章 CAR-T療法のパイプライン分析

第29章 CAR-T療法市場における主要な合併と買収

第30章 CAR-T療法市場の将来の見通しと潜在的な分析

第31章 付録

“CAR-T Therapy Pipeline Analysis Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on car-t therapy pipeline analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for car-t therapy pipeline analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The car-t therapy pipeline analysis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Monotherapy; Combination Therapy

2) By Target Antigen: CD19; CD22; Other Target Antigens

3) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Other Applications

Companies Mentioned: Novartis AG; Kite Pharma; Pfizer Inc.; Juno Therapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the chimeric antigen receptor -T therapy market are: Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, and Immune Therapeutics.

The global car-t therapy pipeline analysis market is expected to grow from $1.40 billion in 2021 to $1.80 billion in 2022 at a compound annual growth rate (CAGR) of 28.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The chimeric antigen receptor -T therapy market is expected to grow to $3.55 billion in 2026 at a CAGR of 18.5%.

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The chimeric antigen receptor -T therapy is a type of immunotherapy in which T-cells are taken from the patient's blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein on a patient's cancer cells. The infused cells multiply and prevail in the patient's body as living drugs.

North America was the largest region in the global CAR-t therapy market in 2022. Western Europe was the second-largest region in the CAR-T therapy market. The regions covered in chimeric antigen receptor -T therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The main types of chimeric antigen receptor -T therapy is monotherapy and combination therapy. Monotherapy is used in the treatment of any disease with a single drug. The target antigens involved are CD19, CD22, and others that are used in various applications such as acute lymphoblastic leukemia, diffuse large b-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

The CAR-T therapy market is driven by the increasing financial support provided by different organizations to promote the development and consumption of CAR-T therapy. The government and non-government organizations provide financial support to the companies in the CAR-T therapy market for research and development and the patients for their treatment of acute lymphoblastic leukemia (ALL). For instance, in December 2021, the University of California San Diego School of Medicine (CA, USA) was granted a funding of US$ 4.1 million for the development of novel chimeric antigen receptor (CAR-T) cell therapy. The grant was awarded by California Institute for Regenerative Medicine (CIRM; CA, USA)*governing board .The financial support provided by different organizations towards CAR-T therapy positively drives the growth of the CAR-T therapy market.

The limitations on the application of CAR-T therapy limit the growth of the market. The limitations of CAR-T therapy include its failure to treat other types of cancer, side effects, and the high cost of treatment. CAR-T therapy is widely used as a treatment for a particular type of blood cancer and fails to treat other types of cancers such as lung cancer or breast cancer. Further, in many cases, the application of CAR-T therapy results in cytokine release syndrome (CRS). CRS is a severe flu-like condition causing high fever, nausea, chills, headache, rash, and troubled breathing. Further, the high cost limits the growth of the market. According to a report from Kaiser Health News, the per-patient cost of CAR-T cell therapy was more than $1 million in 2021. Thus, the growth of CAR-T therapy is restricted by the various limitations on the application of CAR-T therapy.

The companies in the CAR-T therapy market are conducting clinical trials to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple myeloma is a type of white blood cell cancer where the cancer cells accumulate in the bone marrow and surrounds the healthy blood cells. CAR-T therapy is being tested as a treatment for multiple myeloma. CAR-T cells are modified to target the multiple myeloma causing cells to treat the relapsed or refractory multiple myeloma (RRMM). For instance, in December 2021, Novartis announced the introduction of T-Charge™, the company's next-generation CAR-T platform that will serve as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The product was in the early clinical stage (Phase I).

In January 2020, Astellas Pharma, a Japan-based pharmaceuticals company acquired Xyphos for $120m(€107m). The acquisition would add five pre-clinical candidates to Astellas Pharma's portfolio. Xyphos is a US-based CAR-T cell therapy developer.

The countries covered in the chimeric antigen receptor -T therapy market are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The chimeric antigen receptor -T therapy market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor -T therapy market statistics, including chimeric antigen receptor -T therapy industry global market size, regional shares, competitors with a chimeric antigen receptor -T therapy market share, detailed chimeric antigen receptor -T therapy market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor -T therapy industry. This chimeric antigen receptor -T therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. CAR-T Therapy Market Characteristics

3. CAR-T Therapy Market Trends And Strategies

4. CAR-T Therapy Market- Macro Economic Scenario

4.1 COVID-19 Impact On CAR-T Therapy Market

4.2 Ukraine-Russia War Impact On CAR-T Therapy Market

4.3 Impact Of High Inflation On CAR-T Therapy Market

5. CAR-T Therapy Market Size And Growth

• 5.1. Global CAR-T Therapy Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global CAR-T Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. CAR-T Therapy Market Segmentation

• 6.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Monotherapy
• Combination Therapy
• 6.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• CD19
• CD22
• Other Target Antigen
• 6.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Acute Lymphoblastic Leukemia
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Other Applications

7. CAR-T Therapy Market Regional And Country Analysis

• 7.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific CAR-T Therapy Market

• 8.1. Asia-Pacific CAR-T Therapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China CAR-T Therapy Market

• 9.1. China CAR-T Therapy Market Overview
• 9.2. China CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India CAR-T Therapy Market

• 10.1. India CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan CAR-T Therapy Market

• 11.1. Japan CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia CAR-T Therapy Market

• 12.1. Australia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia CAR-T Therapy Market

• 13.1. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea CAR-T Therapy Market

• 14.1. South Korea CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe CAR-T Therapy Market

• 15.1. Western Europe CAR-T Therapy Market Overview
• 15.2. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK CAR-T Therapy Market

• 16.1. UK CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany CAR-T Therapy Market

• 17.1. Germany CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France CAR-T Therapy Market

• 18.1. France CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe CAR-T Therapy Market

• 19.1. Eastern Europe CAR-T Therapy Market Overview
• 19.2. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia CAR-T Therapy Market

• 20.1. Russia CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America CAR-T Therapy Market

• 21.1. North America CAR-T Therapy Market Overview
• 21.2. North America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA CAR-T Therapy Market

• 22.1. USA CAR-T Therapy Market Overview
• 22.2. USA CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America CAR-T Therapy Market

• 23.1. South America CAR-T Therapy Market Overview
• 23.2. South America CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil CAR-T Therapy Market

• 24.1. Brazil CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East CAR-T Therapy Market

• 25.1. Middle East CAR-T Therapy Market Overview
• 25.2. Middle East CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa CAR-T Therapy Market

• 26.1. Africa CAR-T Therapy Market Overview
• 26.2. Africa CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. CAR-T Therapy Market Competitive Landscape And Company Profiles

• 27.1. CAR-T Therapy Market Competitive Landscape
• 27.2. CAR-T Therapy Market Company Profiles
  • 27.2.1. Novartis AG
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Kite Pharma
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Pfizer Inc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Juno Therapeutics
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Celgene Corporation
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. CAR-T Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The CAR-T Therapy Market

30. CAR-T Therapy Market Future Outlook and Potential Analysis

31. Appendix

• 31.1. Abbreviations
• 31.2. Currencies
• 31.3. Historic And Forecast Inflation Rates
• 31.4. Research Inquiries
• 31.5. The Business Research Company
• 31.6. Copyright And Disclaimer